Dr Andrea Hilton

Andrea is a pharmacist who has previously worked in primary care and in community pharmacy.

She gained her undergraduate degree (first class honours) in pharmacy from the University of Bradford in 1999, before completing an MSc in clinical pharmacy while working in secondary care.

Andrea completed her PhD in 2006 while working on the MRC-funded RESPECT trial. Her PhD was entitled Development and Validation of a UK Medication Appropriateness Index.

She has been chair of the local branch of the Royal Pharmaceutical Society, as well as the chair of the Hull Pharmacy Association.

Projects and grants include (sample):

• Can a clinical medication review improve the pharmacological treatment of behaviours in dementia that challenge in care home residents: a pilot study (MEDREV-D) (2014), National Institute for Health Research: Research for patient benefit, £198,000 (co-applicant), lead Aston University

• A qualitative scoping study exploring the role of the community pharmacist in medication management in people with dementia dwelling in the community. (2014) Pharmacy Research UK, £54,000 (co-applicant)

• An exploratory study to establish how pharmacists can facilitate shared decision making which supports the personalised care agenda for patients. (2013) Hull Pharmacists Association, £10,000 (PI)

• Challenge Demcare: Management of challenging behaviour in dementia at home and in care homes. (2007) National Institute for Health Research: Programme Grant, £1.9m (co-applicant)